In a 4-week controlled trial of VYVANSE in pediatric patients ages 13 to 17 years, mean weight loss from baseline to endpoint was -2.7, -4.3, and -4.8 lbs., respectively, for patients receiving 30 mg, 50 mg, and 70 mg of VYVANSE, compared to a 2.0 pound weight gain for patients receiving placebo
You shouldnt take this medication if youre taking a monoamine oxidase inhibitor, if you have heart disease, or if youve had a bad reaction to another stimulant drug
Sources Anti-aging and Sunscreens: Paradigm Shift in Cosmetics, PubMed [accessed 06 February 2025] Decoding the Implications of Glucagon-like Peptide-1 Receptor Agonists on Accelerated Facial and Skin Aging, PubMed [accessed 06 February 2025] Image Analyzer Study of the Skin in Patients With Morbid Obesity and Massive Weight Loss, PubMed [accessed 06 February 2025] Mounjaro KwikPen 10mg solution for injection in pre-filled pen, emc [accessed 06 February 2025] Sunscreen and Prevention of Skin Aging: A Randomized Trial, Annals of Internal Medicine [accessed 06 February 2025] Wegovy 0.25 mg, FlexTouch solution for injection in pre-filled pen, emc [accessed 06 February 2025] Patient Reviews Weight Loss Treatments Further Reading on Weight Loss Do Appetite Suppressants Work
doi:10.1016/S0140-6736(05)61032-X Lu X, Xie Q, Pan X, et al
